本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

97.52
-4.9200-4.80%
成交量:37.49萬
成交額:3,657.92萬
市值:67.14億
市盈率:-31.28
高:101.66
開:101.66
低:96.36
收:102.44
52周最高:122.20
52周最低:74.50
股本:6,885.21萬
流通股本:6,539.41萬
量比:0.92
換手率:0.57%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
淨資產收益率:-117.04%
總資產收益率:-30.96%
市淨率:65.20
市盈率(LYR):-31.36

資料載入中...

2026/09/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/03

重要事件披露

Form 8-K - Current report
2026/03/27

重要事件披露

Form 8-K - Current report